On Monday, Paul B. Manning, CEO of Candel Therapeutics, purchased 550,458 shares of CADL at $5.45 each, totaling approximately $3 million. Following this transaction, Candel Therapeutics saw a 4% increase in its stock price on Friday.
Additionally, on Wednesday, Director Gregg C. Sengstack acquired 25,000 shares of Mueller Water Products for $29.58 each, amounting to a total investment of $739,415. Despite a slight decline of 0.6% in the stock on Friday, Sengstack’s purchase is currently up approximately 4.8%, with shares reaching a trading high of $31.00.
